We are live on
!
Find out more
NLVP
New Leaf Venture Partners Portfolio holdings
AUM
$43M
1-Year Est. Return
25.55%
This Fund
S&P 500
This Quarter
Est. Return
+33.07%
1 Year Est. Return
-25.55%
3 Year Est. Return
+17.13%
5 Year Est. Return
+114.46%
10 Year Est. Return
+1,011.57%
AUM
$43M
AUM Growth
-$9.9M
(-19%)
Cap. Flow
-$604K
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
ITRM
Iterum Therapeutics
ITRM
|
+$343K |
| 2 |
Passage Bio
PASG
|
+$261K |
Sector Composition
| 1 | Healthcare | 100% |
Similar funds
BAM
MAM
WCPI
WAMC
CC
CIEP
IPI
VSAM
New Leaf Venture Partners's Q3 2025 Portfolio in Review
As of Q3 2025, New Leaf Venture Partners held 8 positions worth $43M, down 19% from $52.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
New Leaf Venture Partners's Q3 2025 filing shows 1 reduced and 1 closed positions. The largest sale was Iterum Therapeutics, an estimated $343K.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- New Leaf Venture Partners's biggest Q3 2025 reduction was Passage Bio, cutting an estimated $261K.
- New Leaf Venture Partners fully exited Iterum Therapeutics in Q3 2025, selling an estimated $343K.
- New Leaf Venture Partners's ten largest holdings make up 100% of its $43M portfolio in Q3 2025.
- New Leaf Venture Partners opened 0 new positions and closed 1 in Q3 2025.
- New Leaf Venture Partners's portfolio value fell 19% quarter-over-quarter to $43M.
Based on New Leaf Venture Partners's 13F filing for Q3 2025, filed 14 Nov 2025.